2m 2m 2m 2m 2m 2m 2m
ALLOGENE THERAP (ALLO)
NASDAQ
$2.10+$0.005 (+0.24%)
Price as of Aug 21, 2026 7:50 PM EDT- $722.1MMarket Cap
- 75.63%1-Year Change
- BiotechnologyIndustry
ALLOGENE THERAP (ALLO)
$2.10+$0.005 (+0.24%)
Earnings Score
Valuation | ALLO | vs History | vs S&P 500 |
|---|---|---|---|
Profitability | -1 | ||
Growth | 1 | ||
Low Earnings Volatility | 1 |
Momentum Score
Valuation | ALLO | vs History | vs S&P 500 |
|---|---|---|---|
3-Month Momentum | -3.70% | ||
12-Month Momentum | 62.50% | ||
3-Month Risk Adjusted Momentum | -16.50% | ||
12-Month Risk Adjusted Momentum | 76.20% |
True Yield
Valuation | ALLO | vs History | vs S&P 500 |
|---|---|---|---|
Dividend Yield | N/A | ||
Net Buyback Yield | -0.0006% | ||
Net Debt Paydown Yield | N/A |
Financial Health Score
Valuation | ALLO | vs History | vs S&P 500 |
|---|---|---|---|
Ohlson's O-Score | 5 |